High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: A phase I trial

M. Tempero, P. Leichner, G. Dalrymple, K. Harrison, S. Augustine, J. Schlam, J. Anderson, J. Wisecarver, D. Colcher

Research output: Contribution to journalArticlepeer-review

68 Scopus citations

Fingerprint Dive into the research topics of 'High-dose therapy with iodine-131-labeled monoclonal antibody CC49 in patients with gastrointestinal cancers: A phase I trial'. Together they form a unique fingerprint.

Medicine & Life Sciences